Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
Condition(s):Diabetic Macular EdemaLast Updated:January 16, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Diabetic Macular EdemaLast Updated:January 16, 2024Recruiting
Condition(s):The Condition of Fundus NeovascularizationLast Updated:March 19, 2024Recruiting
Condition(s):Diabetic Macular Edema; Macular Edema Due to Diabetes Mellitus; Retinal Vein OcclusionLast Updated:March 27, 2024Recruiting
Condition(s):Ophthalmological Disorder; Image, BodyLast Updated:July 11, 2023Recruiting
Condition(s):Eye DiseasesLast Updated:February 26, 2024Recruiting
Condition(s):Glaucoma; Vision Impairment and Blindness; Cataract; Diabetic RetinopathyLast Updated:August 15, 2023Not yet recruiting
Condition(s):Uveitis Related Cystoid Macular Edema; Cystoid Macular Edema, PostoperativeLast Updated:November 22, 2023Recruiting
Condition(s):Diabetic Macular EdemaLast Updated:March 13, 2024Recruiting
Condition(s):Diabetic Macular EdemaLast Updated:June 23, 2023Recruiting
Condition(s):Diabetes Mellitus, Type 2; Diabetic AngiopathiesLast Updated:June 2, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.